Drug registration status
▪ A total of 734 clinical approvals of new drugs in 2017, 20 new drug certificates and approval documents and 9 approval documents, and 42 clinical applications were declared in accordance with the new drug application process.
▪ A total of 251 clinical applications for generic drugs and 224 manufacturing applications were approved in 2017.
▪ In 2017, a total of 316 clinical applications for imported drugs were approved, and 93 were listed.
▪ A total of 2158 applications for drug supplementation were approved by the Directorate General in 2017, of which 546 were put on file.A total of 4251 applications for drug supplementation have been approved by the national provincial (district and city) bureau, leaving 12264 for filing.
▪ A total of 552 applications for the manufacture of packaging materials and containers for direct contact with drug products were approved in 2017, 338 applications for re registration, and 62 applications for supplementation.
Lindmik Pharmaceutical(Suzhou)Co.,Ltd is a high-tech pharmaceutical enterprise focusing on the research and development, production and sales of innovative pharmaceutical preparations.Equipped with a number of its own innovative R&D platform of dosage forms, including the transdermal drug delivery system, and at the same time, actively introducing the world’s leading nano-based drug delivery, microspheres drug delivery and other cutting-edge pharmaceutical technologies by means of “license in”, the company is a new rapidly developing company pharmaceutical companies that catches people’s eyes.
12th Floor, Building 5, Tianyun Plaza, 111 Wusongjiang Avenue, Guoxiang Street, Wuzhong District, Suzhou City
0512-66020899
0512-66022699
215124